» Articles » PMID: 15207959

Schizophrenia

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2004 Jun 23
PMID 15207959
Citations 293
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia is a mental illness that is among the world's top ten causes of long-term disability. The symptoms of schizophrenia include psychosis, apathy and withdrawal, and cognitive impairment, which lead to problems in social and occupational functioning, and self-care. About 1% of the population is affected by schizophrenia, with similar rates across different countries, cultural groups, and sexes. The illness tends to develop between the ages of 16 and 30 years, and mostly persists throughout the patient's lifetime. The cause of schizophrenia is unknown, but evidence suggests that genetic factors, early environmental influences (eg, obstetric complications), and social factors (eg, poverty) contribute. No biological alterations are pathognomonic of schizophrenia, although several pathophysiological differences exist in a wide range of brain structures. Antipsychotic medications are the mainstay for managing schizophrenia. A range of psychosocial treatments are also helpful, including family intervention, supported employment, cognitive-behaviour therapy for psychosis, social skills training, teaching illness self-management skills, assertive community treatment, and integrated treatment for co-occurring substance misuse.

Citing Articles

Identification of Schizophrenia-Risk Regulatory Variant rs1399178 in the Non-coding Region With Its Impact on NRF1 Binding.

Ji L, Huang B, Ren D, Wei X, Liu L, Bi Y CNS Neurosci Ther. 2025; 31(3):e70275.

PMID: 40019038 PMC: 11868986. DOI: 10.1111/cns.70275.


Pilot of a team-based quality improvement strategy to improve cardiovascular risk factors care in community mental health centers.

Murphy K, Gennusa J, Dalcin A, Cook C, Goldsholl S, Fink T Front Psychiatry. 2025; 16:1446985.

PMID: 39958153 PMC: 11825777. DOI: 10.3389/fpsyt.2025.1446985.


Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People with Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity Study.

Williams J, Tubiolo P, Gil R, Zheng Z, Silver-Frankel E, Haubold N medRxiv. 2025; .

PMID: 39763546 PMC: 11702713. DOI: 10.1101/2024.12.18.24319241.


Psychotic relapse prediction via biomarker monitoring: a systematic review.

Smyrnis A, Theleritis C, Ferentinos P, Smyrnis N Front Psychiatry. 2024; 15:1463974.

PMID: 39691789 PMC: 11650710. DOI: 10.3389/fpsyt.2024.1463974.


Neutrophil/lymphocyte ratio is increased in the acute phase of schizophrenia and regardless the use and types of antipsychotic drugs.

Zheng Y, Zhou X, Chen K, Fu Z, Zhang P, Zhu Q BMC Psychiatry. 2024; 24(1):876.

PMID: 39627737 PMC: 11613812. DOI: 10.1186/s12888-024-06330-w.